Latest News and Press Releases
Want to stay updated on the latest news?
-
The Medtronic 2019 Integrated Performance Report Shares Progress on Pay Equity, Diversity in Management Roles, Access to Healthcare, Environmental Performance, UN Sustainable Development Goals, and...
-
Data Published in JACC: Clinical Electrophysiology and to be Presented at American Heart Association Scientific Sessions Demonstrates the Potential of Investigational Algorithms in Medtronic Micra...
-
Longest-Term Data from a Real-World PAD Patient Population Presented at VIVA DUBLIN and LAS VEGAS, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced four-year...
-
DUBLIN, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for the second quarter of fiscal year 2020 on Tuesday, November 19, 2019. A...
-
Lower-Profile Thoracic Endovascular Aortic Repair (TEVAR) Device Continues to Broaden Global Treatable Patient Population with Thoracic Aortic Disease DUBLIN, Oct. 31, 2019 (GLOBE NEWSWIRE) -- ...
-
System Offers at Home Therapy Management for DBS patientsUsing Patient-Friendly Consumer Technology DUBLIN and SAN JOSE, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT)...
-
Medtronic Receives FDA “Breakthrough Device Designation” for Developing Fully Implantable Heart Pump
DUBLIN, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received Breakthrough Device designation from the U.S. Food and...
-
DUBLIN, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that Sean Salmon, previously Senior Vice President (SVP) and President, Coronary and Structural Heart (CSH) within...
-
DUBLIN and BARCELONA, Spain, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the launch of GI Genius™ intelligent endoscopy...
-
DUBLIN, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) has classified the company’s voluntary field action initiated in March...